KMG Capital Partners

Circuit Clinical was born from the experiences of a physician conducting clinical research in his busy private practice. From the core belief that patients prefer to learn about clinical research from healthcare providers they trust, came the vision for Circuit Clinical. Since 2015 we've built one of the largest Integrated Research Organizations [IRO] in the US. Our focus on physician and participant engagement gives us a distinct advantage with the identification of motivated participants through direct HIPAA/FDA-compliant Electronic Medical Record (EMR) review. Coupled with our technology products that enhance the participant and physician experience, Circuit Clinical provides our network of more than 1 million patients, our physicians, and our sponsor partners with a new path forward in clinical research.

TriSalus Life Sciences, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The company's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.

Bottlenose is a cognitive computing company that makes data analysis easy. By automating machine learning, data mining, and predictive analytics, Bottlenose helps its clients spend more time extracting insights and less time managing data. The company's platform, Nerve Center, makes BI live and interactive. It detects patterns and trends in massive amounts of rapidly changing data to help customers achieve business awareness and complete insight into what is going on in and around the organization. The company was founded in 2010 and headquartered in Sherman Oaks, California.

Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.

Wildflower Health focuses on its client's needs and integrates services into existing sustainability programs. Its team is passionate about harnessing user-centered design and technology to deliver products that drive smarter healthcare decisions. It was founded in 2012 and headquartered in San Francisco, California.

FitBionic is located in Boulder, Colorado, an international epicenter of health and fitness. We are dedicated to one principle: that amputees deserve whole-person care. We believe in stimulating healthy, active lifestyles, and in offering bionics that feel as comfortable, lively, and functional as their biological equivalents. Since our founding, our R&D has been funded by the National Institutes of Health, and we've demonstrated that it's possible to create high-quality, affordable prosthetic feet that may walk more safely over any terrain, reduce pain and fall risk, and particularly serve the needs of amputees with diabetes. Our first product, the FitBionic Foot, has been demonstrated to allow amputees to walk more efficiently than with carbon fiber feet, and additional early data now points to other benefits as well, including improved overall activity and fitness. Most importantly, the first amputees to use this biomechanically designed walking foot have loved it from the first steps.